PP4 Effect of agonists of peroxisome proliferator-activated receptor χ on cartilage degradation and matrix metalloproteinase production  by unknown
$2 
PP3 
INCREASED LIFE-SPAN OF OSTEOARTHRITIC CHONDRO- 
CYTES BY EXOGENOUS EXPRESSION OF TELOMERASE 
S. Piera-Velazquez, S.A. Jimenez D.G. Stokes 
Division of Rheumato/ogy, Thomas Jefferson University, 
Phi/ade/phia, USA 
Aim: The aim of this study was to induce the expression of the 
catalytic omponent of human telomerase in human osteoarthrit- 
ic (OA) chondrocytes in order to immortalize them and to study 
the effects on their growth and chondrocytespecific gene expres- 
sion pattern. 
Methods: Human OA articular chondrocytes isolated from the 
femoral head and tibial plateau were cultured as monolayers and 
infected with a retroviral-tetomerase expression construct fol- 
lowed by G418 selection. Telomerase repeat amplification (TRAP) 
arid telomere length (TRF) assays were performed on pools of 
transduced cells. Growth kinetics and population doubling 
capacity were assessed by serial passaging ir~ monolayer cul- 
tures. Re-differentiation was induced by transfer to suspension 
culture on polyHEMA-coated ishes and expression of the chon- 
drocyte-specific phenotype was monitored by RT-PCR and 
Northern hybridizations. 
Results: OA chondrocytes from donors of different ages were 
transduced with a retroviral construct expressing telomerase. 
After selection, cells from the three donors expressed telomerase 
activity. After subsequent passaging, lengthening of telomeres 
was observed. Chondrocytes expressing telomerase showed an 
increase in population doublings and continued growing for over 
100 days. The transduced re-differentiated cells expressed a 
chondrocyte specific-phenotype as evidenced by a reduction in 
expression of type I collagen and expression of type II collagen 
and aggrecan mRNA. 
Conclusions: induced expression of telomerase in human OA 
chondrocytes resulted in increased population doubling capacity 
and telomere lengthening while allowing the continued expres- 
sion of chondrocyte-specific genes. 
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EFFECT OF AGONISTS OF PEROXlSOME PROLIFERATOR- 
ACTIVATED RECEPTOR Z ON CARTILAGE DEGRADATION 
AND MATRIX METALLOPROTEINASE PRODUCTION 
M. Sabatini, C. Lesur, A. Bardiot, L Richard, M. Thomas, A. 
Fradin Division of Rheumatology, Institut de Recherches Servier, 
Suresnes, France 
Aim: It was recently shown that agonists of peroxisome prolifer- 
ator-activated receptor (PPAR) X oppose interleukin (IL)- 1- 
induced a) MMP-13 and NO production and b) inhibition of pro- 
teoglycan synthesis by articular chondrocytes. In the present in 
vitro study we examined the effect of PPARz agonists 15d-PGJ 2 
and GI262570 on IL-1 induced aggrecanase- and MMP-depend- 
ent proteoglycan degradation in cartilage exptants. We also test- 
ed agonist effect on production of MMP-2, -3 and -9 by isolated 
chondrocytes. 
Methods: Explants of rat articular cartilage were used in experi- 
ments of tissue degradation. Proteoglycan degradation was 
measured as release of radioactivity from cartilage previously 
labeled with 35S04. Aggrecanase- and MMP-mediated aggrecan 
degradation was examined by western blot of cartilage extracts 
using antisera against NITEGE and VDIPEN, respectively. 
Cultured rat articular chondrocytes were used to study produc- 
tion of MMP-2, -3 and -9 by zymography. 
Results: Two-day culture of cartilage explants with 10 ng/ml IL- 
1!3 stimulated proteoglycan degradation. This effect was likely 
due to aggrecanase, since it was associated with a marked 
increase of NITEGE signal. MMP-dependent VDIPEN signal 
increased only after further incubation for 1 day in the presence 
of pro-MMP activator aminophenylmercuric a etate (APMA) (0.5 
mM). Treatment with 15d-PGJ 2 or G1262570 at concentrations 
between 106 and 105 M dose-dependently inhibited IL-1- 
induced proteoglycan degradation measured both before and 
after addition of APMA. The two PPAR agonists also inhibited IL- 
l-induced production of MMP-3 and -9 by isolated chondro- 
cytes. 
Conclusions: These data show that PPARzagonists inhibit IL- 
l -induced aggrecanase and MMP-mediated proteoglycan degra- 
dation. This effect is associated with inhibition of production of 
MMP-3 and -9. These results support the hypothesis that PPARz 
can play an important role in negative control of IL-1 transduction 
pathway and confirm the interest for PPAR-z egonists as candi- 
date inhibitors of cartilage degradation. 
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SYNOVITIS PREDICTS THE ARTHROSCOPIC 
PROGRESSION OF MEDIAL TIBIOFEMORAL KNEE 
OSTEOARTHRITIS 
Xavier Avral 1 , Eve H Pickering 2, Thasia G Woodworth 2, Neil 
Mackillop ~, Maxime Dougados 1 
1 Rend Descartes University, Cochin Hospital, Rheumatology B 
Department, Paris, France;-2pfizer, Groton, US; 3pfizer, 
Sandwich, UK 
Objectives: To evaluate the prevalence of synovitis in painful 
medial tibiofemoral knee osteoarthritis (OA) and to evaluate cor- 
relations between such synovitis and the structural severity of 
medial knee OA. 
Methods: Study design: multicenter, prospective, one year dura- 
tion. Patients: primary painful knee OA (ACR criteria) of the medi- 
al compartment; medial joint space width ~2 mm; at least 10% 
of one cartilage surface of the medial compartment affected by 
superficial fibrillation or worse. Arthroscopic parameters: 
arthmscopy performed under local anaesthesia nd videorecord- 
ed at entry and after one year; medial chondropathy scored by 
using SFA score (0-100) and reader's overall assessment (VAS 
score 100 mm); medial perimeniscal synovium scored as normal 
(few translucent and slender villi, fine vascular network), reactive 
(proliferation of opaque villi), inflammatory (hypervascularization 
and/or proliferation of hypertrophic and hyperemic villi). 
Progression of media/chondropathy: defined by an increase in 
SFA score and VAS score of at least 4.5 and 8.0 after one year, 
respectively, as previously reported; assessment of severity of 
chondropathy by a single central reader blind to chronology of 
paired videotapes. 
Results: 506 patients participated at the cross-sectional study 
(baseline) and 498 of them at the one year longitudinal study 
(mean age: 61.2+7.7 years, female sex: 58.9%, BMI: 30.4+4 7 
mean disease duration: 3.8+2.9 years). The following table sum- 
marizes cross-sectional and longitudinal correlations existing 
between synovitis and chondropathy. 
Arthroscopicparemeters Medial perimeniscal eynovium atbaseline 
Normal Reactive Inflammatory 
Baseline N=252 N=145 N=109 
SFA score (0-100) 30=19 38=20" 41=18" 
VAS score (100ram) 34=17 41±19" 44=17 ° 
Changes after one year N=251 N=144 N=103 
%SFA score progressors 13.1% 14.6% 23.3% "° 
%VAS score progressors 13.9% 13.2% 30.1%'*° 
p-value vs normal: "p£0.0003 "°p=0.02 ""p=0.00O5 
